Wednesday, July 22, 2026

How Will the New U.S. Tariffs Impact Asian Steel and Aluminum Industries?

The U.S. tariff restructuring under Section 232 prompts South Korea to review impacts on steel, aluminum, and copper industries.

U.S. Weighs Visa Overhaul Following Detentions at Hyundai Battery Plant

U.S. plans to reform the visa system to boost foreign investment follows last year's detention of over 300 Korean workers at Hyundai's factory.

“Shipments Up 45% in a Year”: Riding the K-Beauty Boom, This Company Doubles Its Manufacturing Capacity

Viol Medical expands production to meet K-beauty demand, aiming for significant growth and improved quality control by 2029.

Tag: long-acting injectables

IVL3021 vs Wegovy: The Future of Long-Acting Obesity Treatments Revealed

Inventage Lab's IVL3021 shows promising long-term obesity treatment results, outperforming competitors with effective weight maintenance strategies.

Alzheimer’s Breakthrough: Monthly Injections of IVL3003 vs. GB-5001A—Which is More Effective?

New long-acting injectable formulations of donepezil for Alzheimer's aim to improve adherence and efficacy, easing caregiver burdens.

Revolutionary Long-Lasting Injections: How IVL3003 and IVL3004 are Transforming Dementia and Addiction Treatments

Inventage Lab will present promising results from clinical trials of two long-acting injectables at the 2026 AAN meeting in Chicago.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

Long-Acting HIV Treatment Vocabria + Rekambys Offers New Hope with Just Six Injections a Year

Long-acting HIV treatment Vocabria + Rekambys improves adherence and quality of life, reducing daily pill burden to six injections yearly.

Top News

- Our Sponsors Ad -

Follow us